Title : Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus.

Pub. Date : 2001 Jun

PMID : 11407727






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus. Troglitazone insulin Homo sapiens
2 Troglitazone, a new insulin-sensitizer antidiabetic agent, is considered to reduce plasma insulin level and the present study assessed its effect on the coronary circulation of the patients with non-insulin-dependent diabetes mellitus (NIDDM). Troglitazone insulin Homo sapiens
3 Plasma insulin level (pmol/L) decreased from 66.6+/-10.8 to 39.0+/-7.2 with troglitazone, but was unchanged by glibenclamide (58.8+/-7.2 to 66.0+/-10.8). Troglitazone insulin Homo sapiens
4 In conclusion, troglitazone can restore coronary circulation by improving insulin resistance in patients with NIDDM. Troglitazone insulin Homo sapiens